ARTICLE | Clinical News
Myozyme regulatory update
May 1, 2006 7:00 AM UTC
FDA approved a BLA for Myozyme to treat Pompe's disease. GENZ plans to launch the recombinant human acid alpha-glucosidase enzyme ( rhGAA) within 2 weeks. Myozyme is approved in Europe and has Orphan ...